The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Open accessAbstract
Current neural induction protocols for human embryonic stem (hES) cells rely on embryoid body formation, stromal feeder co-culture or selective survival conditions. Each strategy has considerable drawbacks, such as poorly defined culture conditions, protracted differentiation and low yield. Here we report that the synergistic action of two inhibitors of SMAD signaling, Noggin and SB431542, is sufficient to induce rapid and complete neural conversion of >80% of hES cells under adherent culture conditions. Temporal fate analysis reveals the appearance of a transient FGF5(+) epiblast-like stage followed by PAX6(+) neural cells competent to form rosettes. Initial cell density determines the ratio of central nervous system and neural crest progeny. Directed differentiation of human induced pluripotent stem (hiPS) cells into midbrain dopamine and spinal motoneurons confirms the robustness and general applicability of the induction protocol. Noggin/SB431542-based neural induction should facilitate the use of hES and hiPS cells in regenerative medicine and disease modeling and obviate the need for protocols based on stromal feeders or embryoid bodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Noggin is essential for neural lineage induction via bone morphogenic protein (BMP) antagonism (Chambers et al., 2009).”
From Challenges and solutions in transitioning to animal-free standards: a comprehensive analysis of components in human cell-based developmental neurotoxicity assays (2026) · cites this paper as Chambers et al., 2009
Experimental — accuracy not yet measuredIn the citing paper
“Commonly, neural induction in brain organoids includes inhibition of SMAD signalling to inhibit mesoderm and endoderm formation, followed by the provision of specific morphogens and fate-specifying molecules18.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,235
New cell lines from mouse epiblast share defining features with human embryonic stem cells
Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., Gardner, R. L., & McKay, R. D. G. (2007) · Nature · doi:10.1038/nature05972 · Cited by 2,187
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Efficient differentiation of human embryonic stem cells to definitive endoderm
D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E., & Baetge, E. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1163 · Cited by 1,730
Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity
Kawasaki, H., Mizuseki, K., Nishikawa, S., Kaneko, S., Kuwana, Y., Nakanishi, S., Nishikawa, S., & Sasai, Y. (2000) · Neuron · doi:10.1016/s0896-6273(00)00083-0 · Cited by 1,277
Smith, W. C., & Harland, R. M. (1992) · Cell · doi:10.1016/0092-8674(92)90316-5 · Cited by 1,184
Xenopus chordin: A novel dorsalizing factor activated by organizer-specific homeobox genes
Sasai, Y. (1994) · Cell · doi:10.1016/0092-8674(94)90068-x · Cited by 1,122
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,017
Concise Review: A Chemical Approach to Control Cell Fate and Function
Li, W., Jiang, K., & Ding, S. (2011) · Stem Cells · doi:10.1002/stem.768 · Cited by 94
MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells
Parr, C., Katayama, S., Miki, K., Kuang, Y., Yoshida, Y., Morizane, A., Takahashi, J. B., Yamanaka, S., & Saito, H. (2016) · Scientific Reports · doi:10.1038/srep32532 · Cited by 92
Direct Reprogramming of Fibroblasts via a Chemically Induced XEN-like State
Li, X., Liu, D., Ma, Y., Du, X., Jing, J., Wang, L., Xie, B., Sun, D. Q., Sun, S., Jin, X., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.05.019 · Cited by 88
Jovanovic, V. M., Salti, A., Tilleman, H. G., Zega, K., Jukić, M. M., Zou, H., Friedel, R. H., Prakash, N., Blaess, S., Edenhofer, F., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1540-17.2018 · Cited by 93
Transdifferentiation of human adult peripheral blood T cells into neurons
Tanabe, K., Ang, C. E., Chanda, S., Olmos, V. H., Haag, D., Levinson, D. F., Südhof, T. C., & Wernig, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720273115 · Cited by 94
Edri, R., Yaffe, Y., Ziller, M. J., Mutukula, N., Volkman, R., David, E., Jacob‐Hirsch, J., Malcov, H., Levy, C., Rechavi, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms7500 · Cited by 98
Ichiyanagi, N., Fujimori, K., Yano, M., Ishihara-Fujisaki, C., Sone, T., Akiyama, T., Okada, Y., Akamatsu, W., Matsumoto, T., Ishikawa, M., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.02.011 · Cited by 98
Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors
Meharena, H. S., Marco, A., Dileep, V., Lockshin, E. R., Akatsu, G. Y., Mullahoo, J., Watson, L. A., Ko, T., Guerin, L. N., Abdurrob, F., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2021.12.002 · Cited by 92
Generating human intestinal tissues from pluripotent stem cells to study development and disease
Sinagoga, K. L., & Wells, J. M. (2015) · The EMBO Journal · doi:10.15252/embj.201490686 · Cited by 95
Xu, J.-C., Fan, J., Wang, X., Eacker, S. M., Kam, T., Chen, L., Yin, X., Zhu, J., Chi, Z., Jiang, H., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0623 · Cited by 94
Silencing Trisomy 21 with XIST in Neural Stem Cells Promotes Neuronal Differentiation
Czerminski, J. T., & Lawrence, J. B. (2020) · Developmental Cell · doi:10.1016/j.devcel.2019.12.015 · Cited by 95
Stem Cell-Based Therapies for Parkinson Disease
Liu, Z., & Cheung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218060 · Cited by 98
Vazin, T., Ball, K. A., Lü, H., Park, H., Ataeijannati, Y., Head-Gordon, T. L., Poo, M., & Schaffer, D. V. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.005 · Cited by 94
Bianchi, F., Malboubi, M., Li, Y., George, J. H., Jerusalem, A., Szele, F., Thompson, M. S., & Ye, H. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.09.006 · Cited by 91
The TGFβ superfamily in stem cell biology and early mammalian embryonic development
Beyer, T. A., Narimatsu, M., Weiss, A., David, L., & Wrana, J. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.025 · Cited by 94
Gui, H., Schriemer, D., Cheng, W., Chauhan, R. K., Antiñolo, G., Berrios, C., Bleda, M., Brooks, A. S., Brouwer, R. W. W., Burns, A. J., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1174-6 · Cited by 94
Replacing what’s lost: a new era of stem cell therapy for Parkinson’s disease
Fan, Y., Winanto, W., & Ng, S. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-019-0180-x · Cited by 90
DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis
Thiruvalluvan, A., de Mattos, E. P., Brunsting, J. F., Bakels, R., Serlidaki, D., Barazzuol, L., Conforti, P., Fatima, A., Koyuncu, S., Cattaneo, E. F., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.02.022 · Cited by 89
Mazzara, P. G., Muggeo, S., Luoni, M., Massimino, L., Zaghi, M., Valverde, P. T.-T., Brusco, S., Marzi, M. J., Palma, C., Colasante, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17954-3 · Cited by 99
Multiscale 3D phenotyping of human cerebral organoids
Albanese, A., Swaney, J., Yun, D. H., Evans, N. B., Antonucci, J. M., Velasco, S., Sohn, C. H., Arlotta, P., Gehrke, L., & Chung, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-78130-7 · Cited by 92
Patani, R., Hollins, A. J., Wishart, T. M., Puddifoot, C. A., Álvarez, S., de Lera, Á. R., Wyllie, D. J. A., Compston, D. A. S., Pedersen, R. A., Gillingwater, T. H., et al. (2011) · Nature Communications · doi:10.1038/ncomms1216 · Cited by 90
Role of DNMT3B in the regulation of early neural and neural crest specifiers
Martins‐Taylor, K., Schroeder, D. I., LaSalle, J. M., Lalande, M., & Xu, R.-H. (2012) · Epigenetics · doi:10.4161/epi.7.1.18750 · Cited by 89
Stevens, H. E. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00059 · Cited by 90
Du, J., Campau, E., Soragni, E., Jespersen, C., & Gottesfeld, J. M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt386 · Cited by 95
In vitro Models for Seizure-Liability Testing Using Induced Pluripotent Stem Cells
Grainger, A. I., King, M. C., Nagel, D. A., Parri, H. R., Coleman, M. D., & Hill, E. J. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00590 · Cited by 92
Liu, Q., Waltz, S., Woodruff, G., Ouyang, J., Israel, M. A., Herrera, C., Sarsoza, F., Tanzi, R. E., Koo, E. H., Ringman, J. M., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2482 · Cited by 91
Strategies for bringing stem cell-derived dopamine neurons to the clinic—The NYSTEM trial
Studer, L. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2017.02.008 · Cited by 89
Self-citationHuman Cerebral Organoids and Fetal Brain Tissue Share Proteomic Similarities
Nascimento, J. M., Saia-Cereda, V. M., Sartore, R., da Costa, R. M., Schitine, C., Freitas, H. R., Murgu, M., Reis, R. A. D. M., Rehen, S. K., & Martins‐de‐Souza, D. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00303 · Cited by 92
Dorsal-ventral patterned neural cyst from human pluripotent stem cells in a neurogenic niche
Zheng, Y., Xue, X., Irizarry, A. M. R., Li, Z., Shao, Y., Zheng, Y., Zhao, G., & Fu, J. (2019) · Science Advances · doi:10.1126/sciadv.aax5933 · Cited by 89
Rosebrock, D., Arora, S., Mutukula, N., Volkman, R., Gralinska, E., Balaskas, A., Aragonés Hernández, A., Buschow, R., Brändl, B., Müller, F.-J., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00929-5 · Cited by 89
Experimental models of Parkinson's disease: Challenges and Opportunities
Lal, R., Singh, A., watts, S., & Chopra, K. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176819 · Cited by 94
Soluble Amyloid Precursor Protein Induces Rapid Neural Differentiation of Human Embryonic Stem Cells
Freude, K., Penjwini, M., Davis, J. L., LaFerla, F. M., & Blurton-Jones, M. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227421 · Cited by 102
Cell Therapy for Parkinson’s Disease
Yasuhara, T., Kameda, M., Sasaki, T., Tajiri, N., & Date, I. (2017) · Cell Transplantation · doi:10.1177/0963689717735411 · Cited by 121
Axial elongation of caudalized human organoids mimics aspects of neural tube development
Libby, A. R. G., Joy, D. A., Elder, N. H., Bulger, E. A., Krakora, M. Z., Gaylord, E. A., Mendoza-Camacho, F. N., Butts, J. C., & McDevitt, T. C. (2021) · Development · doi:10.1242/dev.198275 · Cited by 86
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Wang, D., Villenave, R., Stokar‐Regenscheit, N., & Clevers, H. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01317-y · Cited by 111
Frank, S., Zhang, M., Schöler, H. R., & Greber, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041958 · Cited by 89
Lu, B., & Palacino, J. J. (2013) · The FASEB Journal · doi:10.1096/fj.12-219220 · Cited by 89
Kaufmann, M., Schuffenhauer, A., Fruh, I., Klein, J., Thiemeyer, A., Rigo, P., Gomez-Mancilla, B., Heidinger-Millot, V., Bouwmeester, T., Schopfer, U., et al. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115588287 · Cited by 87
Djuric, U., Cheung, A. Y. L., Zhang, W., Mok, R. S. F., Lai, W., Piekna, A., Hendry, J. A., Ross, P. J., Pasceri, P., Kim, D. S., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.01.001 · Cited by 93
Generating trunk neural crest from human pluripotent stem cells
Huang, M., Miller, M. L., McHenry, L. K., Zheng, T., Zhen, Q., Ilkhanizadeh, S., Conklin, B. R., Bronner-Fraser, M. E., & Weiss, W. A. (2016) · Scientific Reports · doi:10.1038/srep19727 · Cited by 88
Chambers, S. M., Mica, Y., Lee, G., Studer, L., & Tomishima, M. J. (2013) · Methods in molecular biology · doi:10.1007/7651_2013_59 · Cited by 87
Self-citationMitochondria in Multiple Sclerosis: Molecular Mechanisms of Pathogenesis
Patergnani, S., Fossati, V., Bonora, M., Giorgi, C., Marchi, S., Missiroli, S., Rusielewicz, T., Wieckowski, M. R., & Pinton, P. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.003 · Cited by 86
Neural stem cell therapy for neurovascular injury in Alzheimer's disease
Boese, A. C., Hamblin, M. H., & Lee, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 89
Zhou, C., Yang, X., Sun, Y., Yu, H., Zhang, Y., & Jin, Y. (2016) · Cell Research · doi:10.1038/cr.2016.15 · Cited by 87
Huehnchen, P., Boehmerle, W., Springer, A., Freyer, D., & Endres, M. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.149 · Cited by 88
Schaffer, A. E., Breuss, M. W., Çağlayan, A. O., Al-Sannaa, N. A., Al-Abdulwahed, H. Y., Kaymakçalan, H., Yılmaz, C., Zaki, M. S., Rosti, R. Ö., Copeland, B. R., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0166-0 · Cited by 86
Chau, M. J., Deveau, T. C., Song, M., Gu, X., Chen, D., & Wei, L. (2014) · Stem Cells · doi:10.1002/stem.1802 · Cited by 87
Lam, M. T., & Longaker, M. T. (2012) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1499 · Cited by 86
Neural Differentiation of Induced Pluripotent Stem Cells
Denham, M., & Dottori, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-328-8_7 · Cited by 86
Concise Review: The Promise of Human Induced Pluripotent Stem Cell-Based Studies of Schizophrenia
Brennand, K., & Gage, F. H. (2011) · Stem Cells · doi:10.1002/stem.762 · Cited by 87
Differentiation of Human Limbal-Derived Induced Pluripotent Stem Cells Into Limbal-Like Epithelium
Sareen, D., Saghizadeh, M., Ornelas, L., Winkler, M. A., Narwani, K., Sahabian, A., Funari, V. A., Tang, J., Spurka, L., Punj, V., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0076 · Cited by 86
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells
Huggins, I. J., Bos, T. J., Gaylord, O. J., Jessen, C., Lonquich, B., Puranen, A., Richter, J., Rossdam, C., Brafman, D. A., Gaasterland, T., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01203-1 · Cited by 85
Fedorová, V., Váňová, T., Elrefae, L. M. B., Pospíšil, J., Petrášová, M., Kolajova, V., Hudáčová, Z., Baniariova, J., Barák, M., Pešková, L., et al. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101563 · Cited by 90
Wang, C., Tang, X., Sun, X., Miao, Z., Lv, Y., Yang, Y., Zhang, H., Zhang, P., Liu, Y., Du, L., et al. (2011) · Cell Research · doi:10.1038/cr.2011.138 · Cited by 85
Medvedev, S. P., Grigor’eva, E. V., Shevchenko, A. I., Malakhova, A. A., Dementyeva, E. V., Shilov, A. A., Pokushalov, E. A., Zaidman, A. M., Aleksandrova, M. A., Plotnikov, E. Y., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0249 · Cited by 86
Kinney, M. A., Hookway, T. A., Wang, Y., & McDevitt, T. C. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0953-9 · Cited by 87
Lee, C.-T., Chen, J., Kindberg, A. A., Bendriem, R. M., Spivak, C. E., Williams, M. P., Richie, C. T., Handreck, A., Mallon, B. S., Lupica, C. R., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.156 · Cited by 87
Modeling psychiatric disorders with patient-derived iPSCs
Wen, Z., Christian, K. M., Song, H., & Ming, G.-L. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.11.003 · Cited by 84
Boucherie, C., Mukherjee, S., Henckaerts, E., Thrasher, A. J., Sowden, J. C., & Ali, R. R. (2012) · Stem Cells · doi:10.1002/stem.1268 · Cited by 84
Patani, R., Compston, A., Puddifoot, C. A., Wyllie, D. J. A., Hardingham, G. E., Allen, N. D., & Chandran, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007327 · Cited by 88
Noormohammadi, A., Khodakarami, A., Gutiérrez-García, R., Lee, H. J., Koyuncu, S., König, T., Schindler, C., Sáez, I., Fatima, A., Dieterich, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13649 · Cited by 86
Woo, C. J., Maier, V., Davey, R., Brennan, J., Li, G., Brothers, J. F., Schwartz, B. E., Gordo, S., Kasper, A., Okamoto, T. R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616521114 · Cited by 88
Denham, M., Hasegawa, K., Menheniott, T. R., Rollo, B., Zhang, D., Hough, S. R., Alshawaf, A. J., Febbraro, F., Ighaniyan, S., Leung, J., et al. (2015) · Stem Cells · doi:10.1002/stem.1991 · Cited by 84
Adapting human pluripotent stem cells to high-throughput and high-content screening
Desbordes, S. C., & Studer, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.139 · Cited by 83
Self-citationHuman pluripotent stem cell–derived models and drug screening in CNS precision medicine
Silva, M. C., & Haggarty, S. J. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14012 · Cited by 88
Midbrain Organoids: A New Tool to Investigate Parkinson’s Disease
Smits, L. M., & Schwamborn, J. C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00359 · Cited by 87
Micali, N., Ma, S., Li, M., Kim, S., Mato-Blanco, X., Sindhu, S. K., Arellano, J. I., Gao, T., Shibata, M., Gobeske, K. T., et al. (2023) · Science · doi:10.1126/science.adf3786 · Cited by 82
Tailor, J. K., Kittappa, R., Leto, K., Gates, M., Borel, M., Paulsen, O., Spitzer, S., Káradóttir, R. T., Rossi, F., Falk, A., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0130-13.2013 · Cited by 85
Ding, S., Kingshott, P., Thissen, H. W., Pera, M. F., & Wang, P. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26075 · Cited by 84
Haston, K. M., & Finkbeiner, S. M. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103548 · Cited by 84
Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson’s Disease
Chlebanowska, P., Tejchman, A., Sułkowski, M., Skrzypek, K., & Majka, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030694 · Cited by 84
Kang, S., Chen, X., Gong, S., Yu, P., Yau, S., Su, Z., Zhou, L., Yu, J., Pan, G., & Shi, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-12452-x · Cited by 89
Daily, K., Ho Sui, S. J., Schriml, L. M., Dexheimer, P. J., Salomonis, N., Schroll, R., Bush, S., Keddache, M., Mayhew, C., Lotia, S., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.30 · Cited by 81
Hou, P.-S., Chuang, C.-Y., Kao, C.-F., Chou, S., Stone, L., Ho, H., Chien, C. L., & Kuo, H. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt567 · Cited by 84
Badenes, S. M., Fernandes, T. G., Cordeiro, C. S. M., Boucher, S., Kuninger, D., Vemuri, M. C., Diogo, M. M., & Cabral, J. M. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151264 · Cited by 81
3-D Bioprinting of Neural Tissue for Applications in Cell Therapy and Drug Screening
Thomas, M., & Willerth, S. M. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00069 · Cited by 80
Fujiwara, N., Shimizu, J., Takai, K., Arimitsu, N. N., Saito, A., Kono, T., Umehara, T., Ueda, Y., Wakisaka, S., Tomoko, S., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.043 · Cited by 84
Gill, J. G., Langer, E. M., Lindsley, R. C., Cai, M., Murphy, T. L., Kyba, M., & MURPHY, K. M. M. (2011) · Stem Cells · doi:10.1002/stem.628 · Cited by 80
Livesey, M. R., Magnani, D., Cleary, E. M., Vasistha, N. A., James, O. T., Selvaraj, B. T., Burr, K., Story, D., Shaw, C. E., Kind, P. C., et al. (2016) · Stem Cells · doi:10.1002/stem.2273 · Cited by 79
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
Pardo, A. D., Amico, E., Basit, A., Armirotti, A., Joshi, P. K., Neely, M. D., Vuono, R., Castaldo, S., Digilio, A. F., Scalabrì, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05709-y · Cited by 81
Li, Z., Sakamuru, S., Huang, R., Brecher, M. B., Koetzner, C. A., Zhang, J., Chen, H., Qin, C., Zhang, Q.-Y., Zhou, J., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.018 · Cited by 81
Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
Hawrot, J., Imhof, S., & Wainger, B. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104680 · Cited by 74
Tristan, C. A., Ormanoglu, P., Slamecka, J., Malley, C., Chu, P.-H., Jovanovic, V. M., Gedik, Y., Jethmalani, Y., Bonney, C., Barnaeva, E., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.11.004 · Cited by 80
Decreased sirtuin deacetylase activity in LRRK2 G2019S iPSC-derived dopaminergic neurons
Schwab, A. J., Sison, S. L., Meade, M. R., Broniowska, K. A., Corbett, J. A., & Ebert, A. D. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.010 · Cited by 80
Han, F., Wang, W., Chen, B.-X., Chen, C., Li, S., Lu, X.-J., Duan, J., Zhang, Y., Zhang, Y., Guo, W., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.02.001 · Cited by 76
Lee, K. S., Zhou, W.-B., Scott-McKean, J. J., Emmerling, K., Cai, G.-Y., Krah, D., Costa, A. C. S., Freed, C., & Levin, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053010 · Cited by 78
Pouya, A., Satarian, L., Kiani, S., Javan, M., & Baharvand, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027925 · Cited by 84
Pruunsild, P., Bengtson, C. P., & Bading, H. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.018 · Cited by 78
Fowler, J. L., Ang, L. T., & Loh, K. M. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.368 · Cited by 87
Chen, C. X. ‐., Abdian, N., Maussion, G., Thomas, R. A., Demirova, I., Cai, E., Tabatabaei, M., Beitel, L. K., Karamchandani, J., Fon, E. A., et al. (2021) · Methods and Protocols · doi:10.3390/mps4030050 · Cited by 91
An overall view of the most common experimental models for multiple sclerosis
Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., & Fadda, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106230 · Cited by 79
Neural stem cells: Brain building blocks and beyond
Bergström, T., & Forsberg‐Nilsson, K. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.665096 · Cited by 83
Leung, A. W., Morest, D. K., & Li, J. Y. H. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.04.023 · Cited by 81
Dooley, D., Vidal, P. M., & Hendrix, S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.08.001 · Cited by 80
Mohamad, O., Drury-Stewart, D., Song, M., Ben, F., Chen, D., Yu, S. P., & Wei, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064160 · Cited by 82
Isolation and differentiation properties of neural crest stem cells
Dupin, É., & Coelho‐Aguiar, J. M. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22098 · Cited by 81
Roles of TGF-β family signals in the fate determination of pluripotent stem cells
Itoh, F., Watabe, T., & Miyazono, K. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.05.017 · Cited by 81
Surmacz, B., Fox, H. D., Gutteridge, A., Lubitz, S., & Whiting, P. J. (2012) · Stem Cells · doi:10.1002/stem.1166 · Cited by 79
Neural stem cells: ready for therapeutic applications?
Casarosa, S., Bozzi, Y., & Conti, L. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-31 · Cited by 79
Heman-Ackah, S. M., Bassett, A. R., & Wood, M. J. A. (2016) · Scientific Reports · doi:10.1038/srep28420 · Cited by 77
Metadata
- Authors
- Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Chambers, Stuart M
- Studer, Lorenz
- Venue
- Nature Biotechnology
- Published
- 2009-03
- Volume
- 27
- Issue
- 3
- Pages
- 275-280
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC2756723
- OpenAlex
- W2087786585
- Cited by
- 3,620
- References
- 24
- Citations by year
- 2026: 155 · 2025: 211 · 2024: 225 · 2023: 241 · 2022: 229 · 2021: 287 · 2020: 292 · 2019: 238 · 2018: 241 · 2017: 235 · 2016: 240 · 2015: 225 · 2014: 185 · 2013: 199 · 2012: 184
- FWCI
- 55.89
- Type
- journal article
- Language
- en
- Update notices
- erratum (2009-05-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS052671)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- neuronal differentiation, human embryonic stem cells, induced pluripotent stem cells, noggin, SB431542, epiblast-like cells, Pax6, rosette formation, midbrain dopaminergic neurons, spinal motoneurons, adherent culture
- MeSH terms
- Noggin Protein, Carrier Proteins, Cell Differentiation, Humans, Mesencephalon, Neurons, Signal Transduction, Cell Culture Techniques, Pluripotent Stem Cells, Smad Proteins, Embryonic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review